154 related articles for article (PubMed ID: 31676217)
61. Revascularization in stable coronary artery disease.
Sherwood MW; Peterson ED
JAMA; 2014 Nov; 312(19):2028-9. PubMed ID: 25399278
[No Abstract] [Full Text] [Related]
62. Dramatic regression of three-vessel disease under statin treatment in patients with stable angina pectoris.
Ercan S; Sari I; Davutoglu V
Ther Adv Cardiovasc Dis; 2012 Dec; 6(6):259-60. PubMed ID: 23196941
[No Abstract] [Full Text] [Related]
63. Diabetes mellitus is not associated with enhanced bleeding risk in patients after percutaneous coronary intervention.
M'Pembele R; Metzen D; Czychy N; Zako S; Mourikis P; Helten C; Trojovsky K; Ignatov D; Petzold T; Thienel M; Vornholz L; Bönner F; Levkau B; Zeus T; Kelm M; Dannenberg L; Polzin A
Diabet Med; 2021 May; 38(5):e14532. PubMed ID: 33511685
[No Abstract] [Full Text] [Related]
64. Controversies in revascularisation for stable coronary artery disease.
Nowbar AN; Rajkumar C; Al-Lamee RK; Francis DP
Clin Med (Lond); 2021 Mar; 21(2):114-118. PubMed ID: 33762369
[TBL] [Abstract][Full Text] [Related]
65. Ample evidence for statins preloading before PCI on periprocedural myocardial infarction among stable angina pectoris patients undergoing percutaneous coronary intervention.
Shariff M; Kumar U A
Cardiovasc Revasc Med; 2019 Jun; 20(6):533-534. PubMed ID: 31000432
[No Abstract] [Full Text] [Related]
66. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30,000 patients.
Takagi H; Manabe H; Kawai N; Goto SN; Umemoto T
Eur Heart J; 2008 Oct; 29(19):2443; author reply 2443-4. PubMed ID: 18682449
[No Abstract] [Full Text] [Related]
67. Comparison of bypass surgery and drug-eluting stenting in diabetic patients with left main and/or multivessel disease: A systematic review and meta-analysis of randomized and nonrandomized studies.
Huang F; Lai W; Chan C; Peng H; Zhang F; Zhou Y; Teng S; Huang Z
Cardiol J; 2015; 22(2):123-34. PubMed ID: 24846507
[TBL] [Abstract][Full Text] [Related]
68. Percutaneous coronary intervention versus coronary-artery bypass grafting.
Shil AB; Aung T; Strohm MP
N Engl J Med; 2009 Jun; 360(25):2673-4; author reply 2674-5. PubMed ID: 19537316
[No Abstract] [Full Text] [Related]
69. Procedure-related bleeding in elective percutaneous coronary interventions.
Ndrepepa G; Stephan T; Fiedler KA; Guerra E; Kufner S; Kastrati A
Eur J Clin Invest; 2015 Mar; 45(3):263-73. PubMed ID: 25645583
[TBL] [Abstract][Full Text] [Related]
70. Coronary artery bypass grafting vs percutaneous coronary intervention in multivessel disease.
Rodriguez AE; Fernandez-Pereira C; Mieres J
JAMA Intern Med; 2014 Jun; 174(6):1007. PubMed ID: 24887763
[No Abstract] [Full Text] [Related]
71. Coronary artery bypass grafting vs percutaneous coronary intervention in multivessel disease.
Takagi H; Umemoto T;
JAMA Intern Med; 2014 Jun; 174(6):1006-7. PubMed ID: 24887761
[No Abstract] [Full Text] [Related]
72. Pre-loading therapy with statins in patients with angina and acute coronary syndromes undergoing PCI.
Lampropoulos K; Megalou A; Bazoukis G; Tse G; Manolis A
J Interv Cardiol; 2017 Dec; 30(6):507-513. PubMed ID: 28786142
[TBL] [Abstract][Full Text] [Related]
73. Effect of two-day atorvastatin pretreatment on long-term outcome of patients with stable angina pectoris undergoing elective percutaneous coronary intervention.
Veselka J; Zemánek D; Hájek P; Malý M; Adlová R; Martinkovičová L; Tomašov P; Tesař D
Am J Cardiol; 2011 May; 107(9):1295-9. PubMed ID: 21349484
[TBL] [Abstract][Full Text] [Related]
74. Ten years after: "I'd love to change the world".
Tommaso CL
Catheter Cardiovasc Interv; 2009 Sep; 74(3):427. PubMed ID: 19681115
[No Abstract] [Full Text] [Related]
75. Coronary artery bypass grafting vs percutaneous coronary intervention in multivessel disease--reply.
Sipahi I
JAMA Intern Med; 2014 Jun; 174(6):1007-8. PubMed ID: 24887764
[No Abstract] [Full Text] [Related]
76. Preprocedural statin therapy, inflammation, and myocardial injury in low-risk stable coronary artery disease patients submitted to coronary stent implantation.
Greque GV; Serrano CV; Strunz CM; Soeiro A; Santos M; Pivateli F; Jacob JL; Pesaro AE; Nicolau JC; Kalil-Filho R
Catheter Cardiovasc Interv; 2016 Feb; 87(2):222-9. PubMed ID: 23592528
[TBL] [Abstract][Full Text] [Related]
77. Myocardial revascularisation in renal dysfunction: a systematic review and meta-analysis.
Deo SV; Shah IK; Dunlay SM; Erwin PJ; Dillon JM; Park SJ
Heart Lung Circ; 2013 Oct; 22(10):827-35. PubMed ID: 23548338
[TBL] [Abstract][Full Text] [Related]
78. Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons.
Arnold SV; Magnuson EA; Wang K; Serruys PW; Kappetein AP; Mohr FW; Cohen DJ;
Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):267-75. PubMed ID: 22496114
[TBL] [Abstract][Full Text] [Related]
79. Major geographical variations in elective coronary revascularization by stents or surgery in England.
Baig SS; Altman DG; Taggart DP
Eur J Cardiothorac Surg; 2015 May; 47(5):855-9. PubMed ID: 25035414
[TBL] [Abstract][Full Text] [Related]
80. Residual high-grade angina after enhanced external counterpulsation therapy.
McCullough PA; Henry TD; Kennard ED; Kelsey SF; Michaels AD;
Cardiovasc Revasc Med; 2007; 8(3):161-5. PubMed ID: 17765644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
